News dal mondo
15
Mag
EU Regulators discuss new pharma legislation, AI, and more
A panel of European regulators answered questions during a town panel discussion at RAPS Euro Convergence 2026 on the implementation of the new EU Pharmaceutical Legislation and the use of artificial intelligence (AI) in regulatory and drug development...[RAPS]
18
Giu
AIFA Sistema informatico Workflow Officine Materie Prime - Ulteriore Aggiornamento tecnico 18 maggio 2026
Formati files ammessi: PDF editabile o p7m. Scansioni a 200 dpi, anche in bianco e nero, per ottimizzare...
15
Mag
US FDA’s New AI-Informed Inspection Pilot and What It Means for Industry
We have written on this blog about FDA’s modernization agenda from several angles lately—from...
15
Mag
US FDA official details top observations from QMSR inspections
The top observations identified in Form 483 reports from inspections conducted under the recently implemented...
15
Mag
European Commission outlines plans to mobilize EMA to diversify supply chains
he European Commission has adopted a Global Health Resilience Initiative that gives EMA a role in diversifying...
le ultime news
08 Mag
Min. Salute Gemmato: “Testo unico farmaceutico entro dicembre 2026”
08 Mag
Precursori droghe: controllo esteso a 9 nuove sostanze dal 18 settembre 2026
08 Mag
US FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
07 Mag
AIFA - Sistema informatico Workflow Officine Materie Prime - aggiornamento
30 Apr
AIFA pubblica il Terzo Position Paper sui farmaci biosimilari
29 Apr
US GDUFA IV Talks Reach Tentative Agreement; America First Application Fee Waiver Added
28 Apr
Sun Pharma compra Organon
27 Apr
US QMM: Participants scored well on commitment to quality, lower on advanced manufacturing